Literature DB >> 23338571

Invasive pulmonary aspergillosis in the ICU: an emerging disease?

Dominic Wichmann, Stefan Kluge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23338571     DOI： 10.1007/s00134-012-2809-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  3 in total

1.  Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores.

Authors:  Sung-Han Kim; Sang-Bum Hong; Sung-Choel Yun; Won-Il Choi; Jong-Joon Ahn; Young Joo Lee; Heung-Bum Lee; Chae-Man Lim; Younsuck Koh
Journal:  Am J Respir Crit Care Med       Date:  2011-03-04       Impact factor: 21.405

2.  Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study.

Authors:  Joost Wauters; Ingrid Baar; Philippe Meersseman; Wouter Meersseman; Karolien Dams; Rudi De Paep; Katrien Lagrou; Alexander Wilmer; Philippe Jorens; Greet Hermans
Journal:  Intensive Care Med       Date:  2012-08-16       Impact factor: 17.440

3.  Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection.

Authors:  I Martin-Loeches; T Lisboa; A Rhodes; R P Moreno; E Silva; C Sprung; J D Chiche; D Barahona; M Villabon; C Balasini; R M Pearse; R Matos; J Rello
Journal:  Intensive Care Med       Date:  2010-11-24       Impact factor: 17.440
  3 in total
  2 in total

1.  Role of the Aspergillus-Specific IgG and IgM Test in the Diagnosis and Follow-Up of Chronic Pulmonary Aspergillosis.

Authors:  Hongxing Li; Yuwen Rui; Wei Zhou; Lulu Liu; Binchan He; Yi Shi; Xin Su
Journal:  Front Microbiol       Date:  2019-06-25       Impact factor: 5.640

2.  An interdisciplinary approach for renal transplant recipients with severe pneumonia: a single ICU experience.

Authors:  Guo-wei Tu; Min-jie Ju; Yi-jun Zheng; Du-ming Zhu; Ming Xu; Rui-ming Rong; Tong-yu Zhu; Zhe Luo
Journal:  Intensive Care Med       Date:  2014-04-29       Impact factor: 17.440
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.